ILMN vs SUPN · rev $2.25B vs rev $426.8M
Illumina Inc (ILMN) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
ILMN currently screens at market cap $15.84B. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the ILMN and SUPN stock pages for the full models.
Not investment advice.